Blue Sea Capital Fund C.V. completes the acquisition of Piramida d.d. in Croatia
Piramida supplies pharmaceutical companies throughout Europe. It is a modern, dynamic company with excellent management, state of the art production facilities and a product portfolio of proven high quality. The Company has full quality control and environmental management systems in place and is ISO accredited wherever relevant. It has a good reputation within the industry and is recognised by the big pharmaceutical players as a reliable supplier with top quality products.
Piramida has enjoyed continuous growth over the last decade and it has recorded an average growth rate of its sales revenue of almost 20% over the last three years. The Company is well positioned to benefit further from the strong growth potential of the pharmaceutical packaging market.
An already strong regional foothold, continuous expansion into new markets, and the proven ability and willingness of the Company to keep abreast of modernisation in technology underpin the attractiveness of the investment.
Sasa Galic, Managing Partner of Blue Sea Capital said: “This is our first investment and we are excited to have the opportunity to lend our support in continuing Piramida’s success story. Over the last decade the previous owners have built a unique platform with a high potential for growth which has been supported by the high quality of its products. We are delighted to work with the management and look forward to helping them achieve the planned results and to introducing further corporate governance procedures and improvements, taking the Company into the future.”
With over 170,000 patient visits every year, and performing over 300,000 procedures annually, Dr Ristic is one of the largest private healthcare providers in Serbia. With an excellent team of managers and almost 200 full and part time doctors and staff, Dr Ristic is synonymous with quality outpatient care in Belgrade.
As a leading player in the sector, Dr Ristic is well positioned to participate in the growth of private healthcare in Serbia in the coming years, setting the standard for quality care and improving the quality of healthcare provision nationwide.
Sasa Galic, Managing Partner of Blue Sea Capital said: “We are pleased to invest in Dr Ristic and in private healthcare in Serbia. Good quality healthcare provision has a universal impact on quality of life and Blue Sea Capital is happy to support the further development of a player who today reaches the most patients out of those present in the Serbian private healthcare sector. Blue Sea Capital is looking forward to working with the management team, doctors and staff of Dr Ristic.”
For further information please contact:
Blue Sea Capital:
Sasa Galic / Mila Cicek
+385 1 6399 510
ABOUT BLUE SEA CAPITAL:
Blue Sea Capital is a regional private equity fund established in July 2011. It has offices in Belgrade and Zagreb.
The latest.
Blue Sea Capital co-investing alongside Actis to acquire telecom tower portfolio in the Western Balkans
Blue Sea Capital (“BSC”) is pleased to announce that, in co-operation with prominent Serbian entrepreneur and investor Andrej Jovanović’s family office (BSC long standing LP), it has agreed to co-invest alongside Actis in the acquisition of the macro tower portfolio of Telekom Srbija. A leading telecommunications operator in the CEE region, Telekom Srbija operates across Serbia, Bosnia & Herzegovina and Montenegro …
Blue Sea Capital completes sale of leading Croatian glass pharmaceutical packaging company to Japanese Nipro Corporation
Blue Sea Capital, a regional private equity fund, has successfully completed the sale of its 100 percent ownership stake in Piramida, a leading Croatian manufacturer of glass pharmaceutical packaging, to Nipro PharmaPackaging International NV, a subsidiary of Nipro Corporation which has its headquarters in Japan…
European Investment Fund approves an investment in Blue Sea Capital Fund II
Blue Sea Capital is pleased to announce that the European Investment Fund (“EIF”) Board of Directors approved an investment in Blue Sea Capital Fund II, subject to satisfactory legal negotiations. EIF is expected to become an anchor investor in Blue Sea Capital Fund II…
Mid Europa and Blue Sea Capital complete Exit from Knjaz Miloš
Blue Sea Capital is pleased to announce that it has completed the sale of Knjaz Miloš, a major player in the production of mineral water and non-alcoholic beverages in Serbia and the surrounding region, to a joint venture between Karlovarské Minerální Vody and PepsiCo, Inc …
Mid Europa and Blue Sea Capital complete Exit from Bambi
Blue Sea Capital is pleased to announce that it has completed the sale of Bambi, the leading biscuit producer in countries of former Yugoslavia with its iconic Plazma brand, to Coca-Cola Hellenic Bottling Company …